Resections in benign and malign lung diseases have to be carried out s
paring parenchyma maximally, in order to preserve the patient's respir
atory functional reserves as much as possible. In malignancies, comple
te surgical remission, how-ever, must be guaranteed in the first place
. Remarkedly, local recurrence of bronchial carcinoma occurs in 19% of
cases after segmental resections, both anatomic and atypical, versus
4% after lobectomy in stage I, the 30-day lethality being 1% versus 5%
, Where pneumonectomy can be avoided, bronchial sleeve resections are
typically required. They are classically indicated on tumor involvemen
t of the origin of the upper lobe bronchus, both with and without lymp
h node metastasis (stages II-IIIA at the right, I-II at the left). In
30% of the cases, bronchial sleeve resections are performed in combina
tion with segmental resection of the associated pulmonary artery. Ther
e is a Nide variety of standardized techniques both at the bronchi and
the vessels. 5-Year survival rates after sleeve resections are 52% in
stage I, 42% in stage II, 18% in stage IIIA, which corresponds with t
he survival rates after standard surgery. 30-day lethality is 7.6% aft
er all sleeve procedures. The typical early complications resulting fr
om bronchial insufficiency occur in 9.4% of cases, which might be redu
ced by the use of modern absorbable monofilament. Vascular complicatio
ns, on the other hand, are very rare. Cicatricial stenoses occur as la
te complications. In the surgery of pulmonary metastases from various
primaries, atypical segmental or wedge resect ions are the procedures
used mast frequently (69%). For parenchyma-sparing resections of metas
tatic lesions, too, sleeve resections both al the bronchial and the va
scular tree are carried out, with the same techniques, variations and
early/late complications as in bronchial carcinoma. The frequently use
d median approach is not adequate for bronchoplasty procedures on the
left lung.